Baird reiterates a 'Neutral' rating on Amgen (Nasdaq: AMGN), new $60 price target.

Baird analyst says, "Given recent management commentary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE